Aparicio J, Virgili A, Capdevila J, Munoz Boza F, et al. Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND). Ann Oncol 2019;30 Suppl 4:iv52.
PMID: 32085197